
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
Walgreens Boots Alliance Inc (WBA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/07/2025: WBA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $12.63
1 Year Target Price $12.63
2 | Strong Buy |
0 | Buy |
11 | Hold |
0 | Sell |
1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -43.65% | Avg. Invested days 19 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.93B USD | Price to earnings Ratio - | 1Y Target Price 12.63 |
Price to earnings Ratio - | 1Y Target Price 12.63 | ||
Volume (30-day avg) 14 | Beta 0.75 | 52 Weeks Range 7.98 - 13.25 | Updated Date 07/7/2025 |
52 Weeks Range 7.98 - 13.25 | Updated Date 07/7/2025 | ||
Dividends yield (FY) 8.71% | Basic EPS (TTM) -7.29 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-06-25 | When Before Market | Estimate 0.3305 | Actual 0.38 |
Profitability
Profit Margin -4.07% | Operating Margin (TTM) 0.74% |
Management Effectiveness
Return on Assets (TTM) 0.83% | Return on Equity (TTM) -69.58% |
Valuation
Trailing PE - | Forward PE 7.35 | Enterprise Value 38131980942 | Price to Sales(TTM) 0.06 |
Enterprise Value 38131980942 | Price to Sales(TTM) 0.06 | ||
Enterprise Value to Revenue 0.25 | Enterprise Value to EBITDA -22.57 | Shares Outstanding 865561024 | Shares Floating 716017757 |
Shares Outstanding 865561024 | Shares Floating 716017757 | ||
Percent Insiders 17.44 | Percent Institutions 61.57 |
Upturn AI SWOT
Walgreens Boots Alliance Inc
Company Overview
History and Background
Walgreens Boots Alliance (WBA) traces its roots back to 1901 when Charles Walgreen Sr. purchased the drugstore where he worked. Over the decades, Walgreens expanded across the United States. In 2014, Walgreens merged with Alliance Boots, forming Walgreens Boots Alliance, a global pharmacy-led health and well-being enterprise.
Core Business Areas
- United States: This segment includes the Walgreens retail pharmacy operations, which provide prescription drugs, health and wellness products, and general merchandise across the US. They offer services like immunizations and health consultations.
- International: Encompasses Boots retail pharmacy operations primarily in the UK and Thailand, plus pharmaceutical wholesale and distribution businesses in several European countries and Latin America.
- Healthcare: This segment focuses on providing care through VillageMD and Shields Health solutions.
Leadership and Structure
The company is led by CEO Tim Wentworth. The organizational structure includes distinct business segments managed by respective leadership teams, all reporting to the CEO and the Board of Directors.
Top Products and Market Share
Key Offerings
- Prescription Medications: Walgreens is a major distributor of prescription drugs in the US. Market share data is difficult to pinpoint exactly due to fragmented reporting, but it's a significant portion of the overall pharmacy market. Competitors include CVS and Rite Aid.
- Health and Wellness Products: Walgreens sells a wide range of over-the-counter medications, vitamins, supplements, and personal care items. Market share varies by product category. Competitors include Walmart, Target, and Amazon.
- Beauty Products: Through the Boots brand, they offer beauty and skincare. Market share is variable by region and specific product line. Competitors include Sephora, Ulta Beauty, and department stores.
Market Dynamics
Industry Overview
The pharmacy and retail healthcare industry is undergoing significant changes, driven by increasing healthcare costs, technological advancements, and evolving consumer preferences. Telemedicine, online pharmacies, and value-based care models are reshaping the landscape.
Positioning
Walgreens Boots Alliance is a major player in the retail pharmacy and healthcare sector. Its competitive advantages include its established brand recognition, extensive retail footprint, and integrated healthcare offerings. They are expanding into primary care and specialty pharmacy.
Total Addressable Market (TAM)
The total addressable market for pharmacy services is substantial, estimated to be several hundred billion dollars globally. Walgreens is well-positioned to capture a significant share of this market with its diverse offerings and expanding healthcare services.
Upturn SWOT Analysis
Strengths
- Extensive retail footprint
- Strong brand recognition
- Integrated pharmacy and healthcare services
- Established international presence
- Loyalty programs (e.g., myWalgreens)
Weaknesses
- High debt levels
- Competition from online retailers
- Dependence on prescription drug sales
- Challenges integrating acquired businesses
- Declining profit margins
Opportunities
- Expansion of healthcare services (e.g., primary care, telehealth)
- Growth in specialty pharmacy
- Strategic partnerships with healthcare providers
- Leveraging data analytics to improve customer experience
- International market expansion
Threats
- Increased competition from online pharmacies
- Reimbursement pressures from pharmacy benefit managers (PBMs)
- Regulatory changes affecting the pharmacy industry
- Economic downturn impacting consumer spending
- Labor shortages
Competitors and Market Share
Key Competitors
- CVS (CVS)
- RITE (RAD)
- AMZN (AMZN)
Competitive Landscape
Walgreens competes with CVS in the retail pharmacy market, with Amazon entering the space through online pharmacy. Walgreens is focusing on healthcare services as a differentiator.
Major Acquisitions
Shields Health Solutions
- Year: 2022
- Acquisition Price (USD millions): 1370
- Strategic Rationale: Strengthened Walgreens' specialty pharmacy capabilities by acquiring the remaining equity interests in Shields Health Solutions, a specialty pharmacy accelerator for hospitals.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been relatively slow in recent years, with challenges in the retail pharmacy sector.
Future Projections: Future growth projections are moderate, contingent on the success of its healthcare services expansion and cost-cutting initiatives. Analyst estimates vary.
Recent Initiatives: Recent strategic initiatives include investments in VillageMD, Shields Health, and the launch of new healthcare service offerings. Sale of Boots UK is planned but the deal has been terminated.
Summary
Walgreens Boots Alliance is facing challenges in the evolving pharmacy and healthcare market, evident in its recent performance and debt. Its strengths lie in its retail footprint and integrated services, but it must navigate increasing competition and reimbursement pressures. Their future depends on the success of their strategic healthcare ventures. Currently, the company is weak, but it's pushing to restructure the business; therefore, it needs to focus on improving its financial health.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Analyst Estimates
- Public News Articles
- SEC Filings (10-K, 10-Q)
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Financial data and market conditions are subject to change. Consult with a qualified financial advisor before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Walgreens Boots Alliance Inc
Exchange NASDAQ | Headquaters Deerfield, IL, United States | ||
IPO Launch date 1985-07-01 | CEO & Director Mr. Timothy C. Wentworth | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 193000 | |
Full time employees 193000 |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.